Position in MESO
as of Jun 30, 2026
· filed Sep 4, 2026
Position Value
$405
-$69,266 QoQ
Shares Held
30
-99.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 72 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MESO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parkside Financial Bank & Trust holds $49,351,632 across 127 Biotechnology names. MESO ranks #119 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
1,329,158 | $47,038,901 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
5,790 | $453,182 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759 | $377,017 | |
| 4 | TECH |
BIO-TECHNE Corp
|
3,596 | $254,056 | |
| 5 | MRNA |
Moderna, Inc.
|
1,774 | $124,233 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
167 | $104,131 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,050 | $102,354 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
2,302 | $89,801 |
All Filings in MESO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $405 | 30 | Shares | Sole | 2026-09-04 | |
| 2026-03-31 | $69,671 | 4,530 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $81,721 | 4,530 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $72,495 | 4,500 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||